Examines the role of rosiglitazone (RSG) in enhancing insulin secretory response via phosphatidylinositol 3-kinase pathway (PI3K). Inhibition of the effect of RSG on insulin secretion; Potentiation of glucose-induced insulin secretion by RSG; Role of PI3K pathway in RSG.